Gene · 3161
Papers2,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The essential roles of FXR in diet and age influenced metabolic changes and liver disease development: a multi-omics study. | Biomark Res | 2023 | 36803569 | PubTator, text mining | PubMed |
| KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma. | Front Oncol | 2023 | 36776306 | PubTator, text mining | PubMed |
| The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer. | Int J Mol Sci | 2023 | 36769170 | PubTator, text mining | PubMed |
| Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway. | Int J Mol Sci | 2023 | 36768316 | PubTator, text mining | PubMed |
| Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies. | Cancers (Basel) | 2023 | 36765928 | PubTator, text mining | PubMed |
| Hyaluronan in the Cancer Cells Microenvironment. | Cancers (Basel) | 2023 | 36765756 | PubTator, text mining | PubMed |
| Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment. | Cancers (Basel) | 2023 | 36765684 | PubTator, text mining | PubMed |
| HELLPAR/RRM2 axis related to HMMR as novel prognostic biomarker in gliomas. | BMC Cancer | 2023 | 36750807 | PubTator, text mining | PubMed |
| HMMR promotes prostate cancer proliferation and metastasis via AURKA/mTORC2/E2F1 positive feedback loop. | Cell Death Discov | 2023 | 36750558 | PubTator, text mining | PubMed |
| LncRNA LINC01833 is a Prognostic Biomarker and Correlates with Immune Infiltrates in Patients with Lung Adenocarcinoma by Integrated Bioinformatics Analysis. | J Oncol | 2023 | 36742153 | PubTator, text mining | PubMed |
| Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics. | Blood Cancer J | 2023 | 36737429 | PubTator, text mining | PubMed |
| Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | Mol Cell | 2023 | 36736316 | PubTator, text mining | PubMed |
| Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine. | Front Pharmacol | 2023 | 36733504 | PubTator, text mining | PubMed |
| Landscape of pathogenic mutations in premature ovarian insufficiency. | Nat Med | 2023 | 36732629 | PubTator, text mining | PubMed |
| Hsa_circ_0005273 acts as a sponge of miR-509-3p to promote the malignant behaviors of breast cancer by regulating HMMR expression. | Thorac Cancer | 2023 | 36727613 | PubTator, text mining | PubMed |
| An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers. | EBioMedicine | 2023 | 36724681 | PubTator, text mining | PubMed |
| Characterization of Hyaluronan Localization in the Developing Mammary Gland and Mammary Tumors. | J Mammary Gland Biol Neoplasia | 2023 | 36723776 | PubTator, text mining | PubMed |
| Extracellular Matrix (ECM) and Fibrosis in Adipose Tissue: Overview and Perspectives. | Compr Physiol | 2023 | 36715281 | PubTator, text mining | PubMed |
| Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics. | Biomed Res Int | 2023 | 36714024 | PubTator, text mining | PubMed |
| 5-mRNA-based prognostic signature of survival in lung adenocarcinoma. | World J Clin Oncol | 2023 | 36699627 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3161/papers?page=17